TG Therapeutics Inc (STU:NKB2)
€ 15.288 0.628 (4.16%) Market Cap: 2.42 Bil Enterprise Value: 2.33 Bil PE Ratio: 77.18 PB Ratio: 16.39 GF Score: 72/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1